2022 - Page 2

Published June 7, 2022 2:18 PM

PharmaSafe researchers set out to answer the question "Is prenatal exposure to triptans associated with an increased risk of attention-deficit/hyperactivity disorder (ADHD) in offspring?". 

Published June 7, 2022 1:59 PM

PharmaSafe doctoral candidate Gerd Marie Eskerud Harris defends her thesis "Migraine pharmacotherapy during pregnancy: Utilization patterns and associations with child neurodevelopment" for the degree of Philosophiae Doctor.

Published Mar. 20, 2022 9:08 PM

Marion Taine is a researcher in epidemiology and a paediatrician. She joins PharmaSafe to contribute to the IMI concePTION project assessing migraine drug utilisation during pregnancy. We wish her a warm welcome! Below, Marion presents herself.

Published Mar. 9, 2022 1:40 PM

Did you know that the experiences of each and every one of us are important to understand the side effects of medications? In the fourth and last video in our series of PharmaSafe videos, researcher Angela Lupattelli and professors Hedvig Nordeng and Anne Gerd Granås discuss medications and side effects with the "Twitter doctor" Wasim Zahid. 

Published Feb. 24, 2022 8:53 PM

PhD candidate Anette Vik Jøsendal and co-authors recently published an article in BMC Health Services Research, studying the implementation of an electronically shared medication list in primary care in Oslo. Read more about the study here!

Published Feb. 23, 2022 10:12 AM

Are we too scared of using medications while breastfeeding? In the second video in our series of four PharmaSafe videos, professor Hedvig Nordeng discusses breastfeeding and medication use with the "Twitter doctor" Wasim Zahid. 

Published Feb. 20, 2022 7:39 PM

Join us for an evening full of pharmacy history and stories from those who helped change our pharmaceutical practices, from the time before regulations and privatization to the present day.

Published Jan. 13, 2022 10:12 PM

Elisabeth Pedersen holds a Master in Pharmacy, and a PhD in pharmacoepidemiology from the Arctic University of Norway in Tromsø (UiT). She now joins PharmaSafe to contribute to the COVID-19 related projects, including the EU-COVID-19, and the Nordic COHERENCE. We wish her a warm welcome! Below, Elisabeth presents herself.

Published Jan. 4, 2022 2:15 PM

Jing Zhao joins PharmaSafe. She has a background in biostatistics, and will be part of the Nordic COHERENCE project to evaluate the impact of COVID-19 on vulnerable populations. She presents herself below. Welcome!